Comparison of the efficacy of Shira Microclamps and Acland Microclamps

Double Blind, Randomized Control Trial to compare the efficacy of Shira Microclamps and Acland Microclamps

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035038

Enrollment

Registered

2021-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C04- Malignant neoplasm of floor of mouth Health Condition 3: C00- Malignant neoplasm of lip Health Condition 4: V80-V89- Other land transport accidents

Interventions

Intervention1: Use Of new, innovative Shira clamp for Microvascular anastamosis: The Shira Clamp offers a novel vessel eversion feature, which keeps the vessel walls open even after occlusion. This fe

Eligibility

Inclusion criteria

Inclusion criteria: Patients requiring microvascular anastamosis Patients willing to consent for study

Exclusion criteria

Exclusion criteria: Presence of active infection Patients unfit for surgery Patients requiring end to side anastamosis

Design outcomes

Primary

Measure	Time frame
Clamp time Suture time Ease of use Need for Clamp flipping Need for assistantTimepoint: Intra-operative	—

Secondary

Measure	Time frame
Flap PatencyTimepoint: Day 1 Day 2 Day 3 Day 4 Day 5	—

Countries

India

Contacts

Public ContactDr Aakash Kohli

AIIMS Jodhpur

aakashkohli22@gmail.com9919960327

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026